← Leaderboards
David A. Knorr
Rockefeller University
$636,027
Attributed
$636,027
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $212K · FY2020–22$250K$187.5K$125K$62.5K$0
'20
'21
'22
Funding mix
By agency
NIH$636,027 · 1
By mechanism
K08$636,027 · 1
Top collaborators
No co-investigators on record.
Most similar at Rockefeller University
Same institution · by research overlap
- Jeffrey Victor Ravetch$66,226,718
- Mikael Karlsson$1,356,393
- Ralph M. Steinman$21,317,958
- Barry Coller$100,984,073
- F. Nina Papavasiliou$7,952,473
Others in their field
Other Emerging Leaders on “Advisory Committees”
- Claudia Valmonte · The Emmes Company, Llc$37,865,589
- James Lu · Helix$12,461,593
- Hemali Phatnani · New York University School Of Medicine$12,067,974
- Patrick A Flume · Medical University Of South Carolina$11,656,627
- Sonia Savelli · University Of Washington$11,147,222
- Rajni Samavedam · Booz Allen Hamilton$9,935,296
Research focus
Advisory CommitteesAgonistAntibodiesAffectAntibody TherapyAnti-Cd40Antigen PresentationAntigen-Presenting CellsAntigen-Specific T CellsAnti-Pd1 AntibodiesAnti-Pd1 TherapyBacillus Calmette-Guerin TherapyBaseBcg LiveBindingBladder NeoplasmBlocking AntibodiesCancer CareCancer ImmunotherapyCancer ModelCareer DevelopmentCareer MobilityCd40 LigandCd8-Positive T-Lymphocytes
Grant awards (3)
Fc-enhanced CD40 agonist antibodies for immune modulation of the tumor microenvironment$212,009
K08 · FY2022 · CA · contact PI
Fc-enhanced CD40 agonist antibodies for immune modulation of the tumor microenvironment$212,009
K08 · FY2021 · CA · contact PI
Fc-enhanced CD40 agonist antibodies for immune modulation of the tumor microenvironment$212,009
K08 · FY2020 · CA · contact PI